retatrutide nonalcoholic steatohepatitis trial fatty liver disease nash A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis NASH Study | Fatty Liver

Smaller portions, higher protein, and functional ingredients are quickly becoming baseline expectations across the food industry

Its a small detail that makes a huge difference over the long term

Mochi Health Founded: 2022 Total raised: $1.15 million, according to PitchBook What Mochi Health does: Mochi launched in 2022 as an online weight-loss platform offering prescriptions for weight-loss medications and virtual visits with obesity-medicine physicians

Gastric bypass can have a strong metabolic effect and may be considered for patients with type 2 diabetes, but the best option depends on the patients full medical history and should be discussed with a bariatric surgeon

Prescribing outside the licensed indications and doses constitutes off-label use, which requires prescribers to document their rationale, obtain informed consent, and provide appropriate monitoring

The GLP-1 drugs that caused the most diarrhea were tirzepatide and semaglutide